Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases

Inclusion Criteria: 1. Patients diagnosed with spinal diseases (KCD codes M and S). 2. Patients whose Numeric Rating Scale (NRS) score for the most predominant pain (neck pain with upper limb radiating pain OR low back pain with lower limb radiating pain) caused by spinal diseases is 5 or higher. 3. Outpatients or inpatients scheduled to utilize an ultrasound scan during pharmacopuncture (the decision to perform ultrasound-guided pharmacopuncture is made according to the clinician's routine medical judgment, not for research purposes). 4. Patients who voluntarily agree to participate in the clinical study and sign the informed consent form. Exclusion Criteria: 1. Patients who have difficulty completing the written informed consent form. 2. Women who are pregnant, planning to become pregnant, or breastfeeding. 3. Patients deemed inappropriate for study participation by the investigator due to severe underlying diseases (e.g., cancer or other malignant neoplasms) that may interfere with treatment effects or result interpretation. 4. Individuals who are deemed unsuitable for participation in the clinical study by the researcher.